Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells

Ähnliche Einträge

• Structural Diversity and Mutational Challenges of Toll‐Like Receptor 4 Antagonists as Inflammatory Pathway Blocker
  von: S. K. Batin Rahaman, et al.
  Veröffentlicht: (2024)
• Dynorphin A Inhibits the Proliferation, Migration, Invasion, and Stemness of Triple Negative Breast Cancer Cells
  von: Xiaojiao Liu, et al.
  Veröffentlicht: (2026)
• β‐Elemene Suppresses Proliferation, Migration, and Stemness in Triple‐Negative Breast Cancer by Inhibiting SIX‐1
  von: Jia Liu, et al.
  Veröffentlicht: (2025)
• Selective Antiproliferative and Apoptotic Effects of 2,6‐Diketopiperazines on MDA‐MB‐231 Triple‐Negative Breast Cancer
  von: Flor Paulina Garrido González, et al.
  Veröffentlicht: (2025)
• Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
  von: Jian Guo, et al.
  Veröffentlicht: (2024)